Essential registration dossiers are needed to evaluate drug’s safety and efficacy: MFDS official

Published: 2013-05-30 06:59:00

Updated: 2013-05-30 06:59:00

Drug companies need to submit a minimum registration documentation to fully demonstrate the safety and efficacy of a medicinal product, when they intend to file a drug application, an official from the Ministry of Food and Drug Safety (MFDS) said at a MFDS-related policy information session, Tues...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK